Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects

Gioé-Gallo C, Ortigueira S, Prieto-Díaz R, Contino M, Azuaje J, Perrone MG, Riganti C, Alberga D, Mangiatordi GF, Andújar-Arias A, García-Rey A, Graziano G, Stefanachi A, Val C, Martínez AL, Rebassa JB, Reza D, Selas A, Francavilla F, Paleo MR, García-Mera X, Loza MI, Navarro G, Brea J, Sotelo E.

J Med Chem. 2025 Aug 28;68(16):17103-17129. | https://doi.org/10.1021/acs.jmedchem.5c00604